These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17589345)

  • 21. [Changes of peripheral blood CD4(+)CD25(+) regulatory T cells and TREG-related Foxp3 gene expression at the onset of chronic allograft nephropathy].
    DU C; Yu L; Fu S; Xu J; Wei Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1366-8. PubMed ID: 22985585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
    Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
    Liu L; Deng S; Teng L; Fu Q; Wang C; He X
    Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
    Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Transpl Immunol; 2012 Oct; 27(2-3):114-21. PubMed ID: 22954802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.
    Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
    Transplantation; 1996 Oct; 62(8):1149-60. PubMed ID: 8900317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.
    Mathew JM; Ciancio G; Burke GW; Garcia-Morales RO; Rosen A; Wang E; Gomez CI; Blomberg BB; Fuller L; Esquenazi V; Ricordi C; Miller J
    Hum Immunol; 2010 Jun; 71(6):566-76. PubMed ID: 20153397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation.
    Mathew JM; Carreno M; Fuller L; Ricordi C; Kenyon N; Tzakis AG; Miller J; Esquenazi V
    Transplantation; 1999 Oct; 68(8):1172-80. PubMed ID: 10551647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene transfer method for the study of chimerism derived from donor bone marrow in organ transplant recipients.
    Smith JP; Kasten-Jolly J; Rebellato L; Haisch C; Thomas JM
    Transplant Proc; 1995 Feb; 27(1):158-9. PubMed ID: 7878954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Function of CD4(+) CD25(+) regulatory T cells in Henoch-Schonlein purpura nephritis in children].
    Shao X; Jiang C; Li Y; Jiang X; Xu H; Ying P; Qiu J; Lin J; Zheng S; Chang L; Huang Y
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):516-20. PubMed ID: 25224057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].
    Nie ST; Li Q; Wang HY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):817-9. PubMed ID: 19595120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
    van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
    Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
    Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
    Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.
    Solgi G; Gadi V; Paul B; Mytilineos J; Pourmand G; Mehrsai A; Ranjbar M; Mohammadnia M; Nikbin B; Amirzargar AA
    Chimerism; 2013; 4(3):87-94. PubMed ID: 23639966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses.
    Mathew JM; Fuller L; Carreno M; Garcia-Morales R; Burke GW; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transplantation; 2000 Dec; 70(12):1752-60. PubMed ID: 11152108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation.
    Berglund D; Korsgren O; Lorant T; Schneider K; Tufveson G; Carlsson B
    Transpl Immunol; 2012 Jan; 26(1):27-33. PubMed ID: 21958749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes of FoxP3, CD4(+)CD25(+) regulatory T cells, TLR2 and TLR9 in children with infectious mononucleosis].
    Wang Q; Wang ZF; Cao M; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):469-73. PubMed ID: 23628056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.